FRACTURES IN A UK PAEDIATRIC PRIMARY CARE POPULATION WITH OR WITHOUT GASTROESOPHAGEAL REFLUX DISEASE: NO ASSOCIATION WITH USE OF PROTON PUMP INHIBITORS

(1) CEIFE

(2) AstraZeneca



This item was part of the GORD: Manifestations, management and complications session at 20th United European Gastroenterology Week

This item can be cited as: Gut 2012; 61 (Suppl 3) A28